Track topics on Twitter Track topics that are important to you
ALBANY, New York, August 9, 2017 /PRNewswire/ --
Transparency Market Research (TMR), in its recent outlook titled, "D-Mannose Market (Type - Powder, Tablet, and Capsule; Application - Dietary Supplements, Functional Food, Pharmaceuticals, and Animal Feed) - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast 2017 - 2025", projects that in terms of value, Global D-Mannose Market revenue will expand at a CAGR of 3.5% during the forecast period. In terms of revenue, the Global D-Mannose market accounted for around US$ 700 Mn in 2017 and is anticipated to increase to roughly about US$ 1 Bn by 2025.
By finished product type, the market is segmented into powder, tablet and capsule, by application, the market is segmented into dietary supplement, functional food, pharmaceuticals, animal feed and others, by distribution channel, the D-Mannose market is segmented into direct and indirect. According to the study conducted, the capsule is dominant over powder as well as tablet owing to consumer convenience and relatively better absorption. In application segment, dietary supplement is anticipated to dominate over the forecast period on the backdrop of the growing trend of people opting for natural, and non-GMO products. Moreover, by distribution channel, D-Mannose market is segmented into direct and indirect distribution channels. The indirect distribution channel is further sub-segmented into online retail, pharmacies, and specialty drug stores. The indirect distribution channel is expected to account for most of the market share in this segment due to the increasing utilization of D-mannose as a finished product.
This report covers trends driving each segment and offers analysis and insights regarding the potential of the D-Mannose market in specific regions. In terms of volume, Europe and North-America collectively accounted for more than 50% share in the global market in 2025. Also, APAC is expected to become a large market through 2025 in terms of demand, followed by MEA.
Get Sample PDF Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14363
D-Mannose is a natural alternative for prevention and treatment of urinary tract infection (UTI) as opposed to antibiotics, which are liable to resistance. Furthermore, when D-Mannose is ingested, it is quickly absorbed in the upper portion of the gastrointestinal tract, but very little of the sugar is actually metabolized. It therefore does not affect blood sugar levels thereby, makes it safe for everyone, including diabetic patients for consumption. Besides its popular use in the treatment of diseases such as UTI, D-Mannose is used as an inexpensive starting material for synthesis of D-Mannitol. Moreover D-Mannose contains few calories and texture-improving characteristics and hence can also be used in dairy products such as yoghurt, ice-creams, and others. Additionally, D-mannose is not burned for fuel or energy and most of the ingested amount is filtered through kidneys and routed to the bladder for fast excretion making it a very effective probiotic ingredient.
In spite of the evident after effects of consuming antibiotics, patients continue to prefer them over natural alternatives as D-Mannose which is unable to deliver immediate results and take prolonged time for curing. Also, Consumption of D-mannose has its side-effects such as bloating and loose stools. Moreover, the use of D-mannose is not recommended during pregnancy and breastfeeding. Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the D-Mannose space. D-Mannose producer includes VWR Corporation, Atrium Innovations Inc., Ferro Pfanstiehl Laboratories, Inc., Now Health Group Incorporation, Hänseler AG, and Kyowa Hakko Kirin Co Ltd, E. I. du Pont de Nemours and Company, Bio-Tech Pharmacal Inc., Jarrow Formulas Inc., and Nutraceutical International Corporation.
The global d-mannose market is segmented as follows:
Browse Research Press Release: http://www.transparencymarketresearch.com/pressrelease/mannose-dmannose-market.htm
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
SOURCE Transparency Market ResearchNEXT ARTICLE
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...